Nexgenia produces proprietary reagents for molecular and cell separations. These reagents enable efficient, low cost, gentler separations of cells in blood.
Nexgenia develops and manufactures reagents based on proprietary technology licensed from the UW and developed internally. Nexgenia will sell these reagents to companies for use in their products or manufacturing. In particular Nexgenia intends to work with a limited number of biotechnology companies, enabling them to separate and isolate cells in the most efficient cost-effective manner possible. Nexgenia's is a business to business model.